Dr. Tevan Ovsepyan, DO

Dr. Ovsepyan practices at Sub-Acute Care Center in Mission Hills, California.

Dr. Ovsepyan's NPI, 1669635876, was assigned on July 8, 2008. Dr. Ovsepyan graduated from Touro University Nevada in 2008. Dr. Ovsepyan holds California license 20A11148.

Dr. Ovsepyan's primary practice is Sub-Acute Care Center, at 11600a Indian Hills Road, Mission Hills, Ca 91345, Mission Hills, CA 91345 in Los Angeles County. The practice phone is (818) 898-4630. Dr. Ovsepyan also practices at Providence Holy Cross Medical Center, 15031 W Rinaldi St, Mission Hills, CA 91345.

Dr. Ovsepyan's primary practice is Sub-Acute Care Center in Mission Hills, California. Dr. Ovsepyan is also affiliated with Providence Holy Cross Medical Center. The medical group on file is Facey Medical Group. Dmand AI also links Dr. Ovsepyan to 1 more hospital and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ovsepyan practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Ovsepyan's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Ovsepyan is board certified in internal medicine by the American Board of Internal Medicine. Dr. Ovsepyan is licensed in California.

Dmand AI lists acute respiratory failure, congestive heart failure, gastrointestinal bleeding, gastrointestinal inflammation, gastrointestinal obstruction, heart attack, lung disease: COPD, asthma or bronchitis and pneumonia and respiratory infection among the conditions Dr. Ovsepyan treats.

CMS data shows 136 Medicare services from Dr. Ovsepyan across 2 procedure codes in 2024, for 67 Medicare patients. Medicare paid $12,440 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 67 Medicare patients who saw Dr. Ovsepyan in 2024. The largest group is 65 to 74, with 26 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 60% are also on Medicaid. Their average risk score is 2.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ovsepyan's median patient age at 66, with 53% women.

In 2024, Dr. Ovsepyan wrote 180 Medicare Part D claims for 66 patients. 91% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $40 in total drug cost. In 2023, CMS named 37 claims across 3 drugs.

Dr. Ovsepyan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 93 general payments to Dr. Ovsepyan from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. AstraZeneca Pharmaceuticals LP paid the most, $983.

Dr. Ovsepyan graduated from Touro University Nevada in 2008. Dr. Ovsepyan is a member of AAPL, ACP, AMA, AOA and SHM.

Dr. Ovsepyan is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.